Tumor microenvironment responsiveT1–T2dual-mode contrast agent Fe3O4@ZIF-8-Zn–Mn NPs forin vivomagnetic resonance imaging-Reference-Cited by-同舟云学术

Tumor microenvironment responsiveT₁–T₂dual-mode contrast agent Fe₃O₄@ZIF-8-Zn–Mn NPs forin vivomagnetic resonance imaging

Published:2023 Issue:19 Volume:11 Page:4203-4210
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Liang Minmin¹,Zhou Weixiu¹,Zhang Haifeng¹,Zheng Jutian¹,Lin Jiaomin¹²,An Lu¹^ORCID,Yang Shiping¹^ORCID

Affiliation:

1. The Key Laboratory of Resource Chemistry of Ministry of Education, Shanghai Key Laboratory of Rare Earth Functional Materials, Shanghai Normal University, Shanghai, 200234, China

2. School of Chemistry, South China Normal University, Guangzhou 510006, P. R. China

Abstract

A pH and glutathione sensitive assembly Fe3O4@ZIF-8-Zn-Mn was constructedviaone step self-assembly in aqueous solution. This assembly can be used as tumor microenvironment responsiveT1–T2dual-mode magnetic resonance imaging contrast agent for tumor imaging.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shanghai

Ministry of Education of the People's Republic of China

International Joint Laboratory of Resource Chemistry

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB00068K

Reference41 articles.

1. Safe and potent MRI contrast agents by complexing gadolinium with enzyme/reduction dual-sensitive branched polymers

2. Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers

3. Cover Picture: Engineered SAM Synthetases for Enzymatic Generation of AdoMet Analogs with Photocaging Groups and Reversible DNA Modification in Cascade Reactions (Angew. Chem. Int. Ed. 1/2021)

4. Yttrium‐86 Is a Positron Emitting Surrogate of Gadolinium for Noninvasive Quantification of Whole‐Body Distribution of Gadolinium‐Based Contrast Agents

5. SICKLE CELL ASSOCIATED CARDIOMYOPATHY: UTILITY OF T2 WEIGHTED CARDIAC MRI